Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Boston Scientific Corp shares valued at $1,758,189 were sold by Butcher Arthur C on Dec 01 ’25. At $101.55 per share, Butcher Arthur C sold 17,313 shares. The insider’s holdings dropped to 23,600 shares worth approximately $2.16 million following the completion of this transaction.
Also, ARTHUR C BUTCHER purchased 17,313 shares, netting a total of over 1,758,188 in proceeds.
Before that, Zane Ellen M had sold 12,891 shares from its account. In a trade valued at $1,266,978, the Director traded Boston Scientific Corp shares for $98.28 each. Upon closing the transaction, the insider’s holdings decreased to 12,891 shares, worth approximately $2.21 million.
As published in a research note from Erste Group on October 03, 2025, Boston Scientific Corp [BSX] has been rated down from a Buy to a Hold. Analysts at Oppenheimer upgraded the stock from ‘”a Perform”‘ to ‘”an Outperform”‘ outlook in a report released in early September. As of June 16, 2025, Leerink Partners has initiated its “an Outperform” rating for BSX. Earlier on April 16, 2025, Needham upgraded its rating. Their new recommendation was “a Buy” for BSX stock which previously was a “a Hold”.
Analyzing BSX Stock Performance
On last trading session, Boston Scientific Corp [NYSE: BSX] rose 0.56% to $91.71. The stock’s lowest price that day was $90.44, but it reached a high of $92.29 in the same session. During the last five days, there has been a drop of approximately -2.58%. Over the course of the year, Boston Scientific Corp shares have dropped approximately -7.04%.
Is Boston Scientific Corp subject to short interest?
Stocks of Boston Scientific Corp saw a sharp rise in short interest on 2025-12-31 jumping by 1.28 million shares to 20.01 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 18.73 million shares. A jump of 6.38% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.16 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.16.
Which companies own the most shares of Boston Scientific Corp (BSX)?
In terms of Boston Scientific Corp share price expectations, FactSet research, analysts set an average price target of 129 in the next 12 months, up nearly 41.45% from the previous closing price of $91.2. Analysts anticipate Boston Scientific Corp stock to reach 140 by 2026, with the lowest price target being 100. In spite of this, 15 analysts ranked Boston Scientific Corp stock as Buy at the end of 2026. On January 10, 2025, Deutsche Bank assigned a price target of “a Buy” to the stock and upgraded coverage with a $108.
